Marco Lobba obtained his PhD from the University of California Berkeley and was a student in the labs of Nobel Laureate Jennifer Doudna and Matthew Francis, Emeritus Chair of the Berkeley Department of Chemistry. In addition, he holds a bachelor’s degree in from Pomona College. With his educational foundation rooted at the intersection of chemistry, molecular biology and gene editing, Dr. Lobba co-founded CatenaBio to address the pressing challenge of delivering targeted protein therapeutics. His expertise in protein conjugation has helped advance innovative treatments, such as CRISPR-based editors and cell-based therapies. Dr. Lobba’s academic background and experience at UC Berkeley have shaped his vision for revolutionizing precision medicine and developing therapies that were previously unimaginable.